Benzinga · Aug 19, 2026
BTIG Maintains Buy on LifeStance Health Gr, Raises Price Target to $18
BTIG analyst David Larsen maintains LifeStance Health Gr (NASDAQ:LFST) with a Buy and raises the price target from $16 to $18.
LF
NASDAQ · LFST
LifeStance Health Group, Inc.
Healthcare · Medical - Care Facilities
$12.89
Up+$0.09 (+0.67%)
Updated Sep 3, 2026, 5:59 PM
SID Score
6.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 2.63B
- P/E ratio
- -287.34
- Dividend yield
- 0.00%
- 52-week range
- $4.77 – $12.97
- Volume
- 3.92M
- Avg. volume
- 1.9M
Price performance
LFST price history
1M range · 21 trading sessions · Daily adjusted prices
LFST closed at $12.89 after 21 trading sessions, up 24.30% for the selected period.
- Last close
- $12.89
- Period change
- +24.30%
- Period low
- $10.37
- Period high
- $12.89
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 2, 2026 | $12.74 | $13.15 | $12.74 | $12.89 | 3.92M |
| Sep 1, 2026 | $12.27 | $12.755 | $12.27 | $12.60 | 3.47M |
| Aug 31, 2026 | $12.23 | $12.405 | $12.0419 | $12.36 | 3.45M |
| Aug 28, 2026 | $12.31 | $12.59 | $12.235 | $12.31 | 4.05M |
| Aug 27, 2026 | $12.185 | $12.485 | $12.10 | $12.30 | 2.96M |
| Aug 26, 2026 | $12.21 | $12.48 | $12.01 | $12.15 | 4.43M |
| Aug 25, 2026 | $12.19 | $12.295 | $11.915 | $12.28 | 3.62M |
| Aug 24, 2026 | $12.37 | $12.655 | $12.11 | $12.16 | 2.72M |
| Aug 21, 2026 | $12.65 | $12.72 | $12.41 | $12.47 | 2.62M |
| Aug 20, 2026 | $12.70 | $12.965 | $12.605 | $12.65 | 2.31M |
| Aug 19, 2026 | $12.70 | $12.85 | $12.43 | $12.83 | 2.64M |
| Aug 18, 2026 | $12.64 | $12.7499 | $12.33 | $12.36 | 3.52M |
| Aug 17, 2026 | $12.41 | $12.665 | $12.23 | $12.55 | 3.45M |
| Aug 14, 2026 | $12.28 | $12.755 | $12.22 | $12.42 | 5.19M |
| Aug 13, 2026 | $12.11 | $12.40 | $12.02 | $12.22 | 5.04M |
| Aug 12, 2026 | $11.56 | $12.25 | $11.43 | $12.23 | 6.28M |
| Aug 11, 2026 | $11.79 | $11.93 | $11.36 | $11.50 | 6.45M |
| Aug 10, 2026 | $10.85 | $12.425 | $10.85 | $11.90 | 10.56M |
| Aug 7, 2026 | $10.90 | $10.975 | $10.52 | $10.84 | 3.79M |
| Aug 6, 2026 | $10.99 | $10.99 | $10.08 | $10.66 | 9.14M |
| Aug 5, 2026 | $10.36 | $10.565 | $10.08 | $10.37 | 4.36M |
Latest LFST news
The latest Smart Investors Daily articles mentioning LFST.
Stock researchCompany · Overview
LFST research
Overview
Company profile and research snapshot.
Company profile
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. The group y has a single operating and reportable segment of mental health services.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $8.00
- Implied upside
- —
- Analysts
- 15
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 19, 2026 | BTIG | Buy | — |
| Aug 14, 2026 | JP Morgan | Neutral | — |
| Aug 7, 2026 | BTIG | Buy | — |
| Jul 24, 2026 | BTIG | Buy | — |
| Jul 21, 2026 | Canaccord Genuity | Buy | — |
News briefing
No generated briefing is available yet.
Benzinga · Aug 14, 2026
JP Morgan Maintains Neutral on LifeStance Health Gr, Raises Price Target to $13
JP Morgan analyst Lisa Gill maintains LifeStance Health Gr (NASDAQ:LFST) with a Neutral and raises the price target from $9 to $13.
Yahoo · Aug 12, 2026
LifeStance Health Group (LFST) Is Up 12.1% After Profit Turn, Higher Guidance And New Buyback Program
In early August 2026, LifeStance Health Group reported second-quarter results showing higher sales and a move to net profitability, raised its 2026 revenue outlook, and completed a US$97.19 million share repurchase while authorizing a new buyback program of up to US$100 million. Together with new guidance for third-quarter revenue and an expanded focus on clinician productivity and specialty services, these actions signal management’s emphasis on scaling operations while returning capital to...
Yahoo · Aug 12, 2026
5 Low-Leverage Stocks to Buy as High Oil Prices Shake Investor Confidence
High oil prices and market volatility spotlight five low-leverage stocks with strong earnings growth and resilient balance sheets.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
